Patents by Inventor Ihor Shevchuk

Ihor Shevchuk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ABUSE RESISTANT OPIOID TRANSDERMAL DELIVERY DEVICE CONTAINING OPIOID ANTAGONIST MICROSPHERES
    Publication number: 20170157114
    Abstract: The present invention provides abuse-resistant transdermal delivery devices containing an opioid agonist intended for analgesic purposes in pain patients.
    Type: Application
    Filed: December 19, 2016
    Publication date: June 8, 2017
    Inventors: Bruce Reidenberg, Ihor Shevchuk, Lino Tavares, Kevin Long, Richard Maskiewicz, Mohammed Shameem
  • Pharmaceutical formulations for the treatment of alzheimer's disease
    Patent number: 9345722
    Abstract: The present invention relate to pharmaceutical formulations that include a CPHPC component and a delivery agent compound.
    Type: Grant
    Filed: July 24, 2007
    Date of Patent: May 24, 2016
    Assignee: EMISPHERE TECHNOLOGIES, INC.
    Inventors: Ihor Shevchuk, Steven Dinh
  • Loratadine transdermal device and methods
    Patent number: 9259397
    Abstract: A tansdermal delivery device for effectively treating seasonal allergic rhinitis and chronic idiopathic urticariain in humans is disclosed and methods thereof.
    Type: Grant
    Filed: October 23, 2001
    Date of Patent: February 16, 2016
    Assignee: Purdue Pharma L.P.
    Inventors: Lino Tavares, Ihor Shevchuk, Mark Alfonso, Geraldine Marcenyac, Kirti Valia
  • ABUSE RESISTANT OPIOID CONTAINING TRANSDERMAL SYSTEMS
    Publication number: 20140199383
    Abstract: The present invention relates to transdermal dosage form (FIGS. 1-3) comprising at least one activating agent and at least one inactivating agent. The dosage form (FIGS. 1-3) releases the inactivating agent upon disruption of the dosage form (FIGS. 1-3) thereby preventing or hindering misuse of the active agent contained in the dosage form (FIGS. 1-3).
    Type: Application
    Filed: January 21, 2014
    Publication date: July 17, 2014
    Applicant: PURDUE PHARMA L.P.
    Inventors: Lino Tavares, Bruce E. Reidenberg, Richard S. Sackler, Curtis Wright, Mark A. Alfonso, Benjamin Oshlack, James P. Cassidy, Anthony E. Carpanzano, Rampurna P. Gullapalli, Ihor Shevchuk
  • Topical administration of acyclovir
    Patent number: 8771712
    Abstract: The present invention provides a topical composition comprising (a) at least one delivery agent compound and (b) a acyclovir compound. Methods of treatment, and methods of preparing the topical composition are also provided.
    Type: Grant
    Filed: May 2, 2007
    Date of Patent: July 8, 2014
    Assignee: Emisphere Technologies, Inc.
    Inventors: Steven Dinh, Puchun Liu, Ihor Shevchuk
  • Terazosin transdermal device and methods
    Patent number: 8496960
    Abstract: A method of effectively treating benign prostatic hypertension in humans is achieved by administering amorphous terazosin via a transdermal formulation. Preferably, the transdermal formulation is applied to the skin of the patient and maintained in contact with the skin for at least about 24 hours, and preferably for about 3 to about 8 days.
    Type: Grant
    Filed: October 23, 2002
    Date of Patent: July 30, 2013
    Assignee: Purdue Pharma L.P.
    Inventors: Lino Tavares, Ihor Shevchuk, Mark Alfonso, Geraldine Marcenyac, Kirti H. Valia
  • PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
    Publication number: 20100004310
    Abstract: The present invention relate to pharmaceutical formulations that include a CPHPC component and a delivery agent compound.
    Type: Application
    Filed: July 24, 2007
    Publication date: January 7, 2010
    Applicant: Emisphere Technologies Inc.
    Inventors: Ihor Shevchuk, Steven Dinh
  • TOPICAL ADMINSTRATION OF ACYCLOVIR
    Publication number: 20090118168
    Abstract: The present invention provides a topical composition comprising (a) at least one delivery agent compound and (b) a acyclovir compound. Methods of treatment, and methods of preparing the topical composition are also provided.
    Type: Application
    Filed: May 2, 2007
    Publication date: May 7, 2009
    Applicant: Emsiphere Technologies Inc.
    Inventors: Steven Dinh, Puchun Liu, Ihor Shevchuk
  • TRANSDERMAL DELIVERY DEVICE DISPOSAL SYSTEM
    Publication number: 20080274168
    Abstract: The present invention relates to a transdermal delivery device disposal system for disposing of a transdermal delivery device containing at least one pharmaceutically active component.
    Type: Application
    Filed: July 15, 2008
    Publication date: November 6, 2008
    Inventors: Carl J. Baker, Ihor Shevchuk
  • Abuse Resistant Opioid Transdermal Delivery Device Containing Opioid Antagonist Microspheres
    Publication number: 20080233178
    Abstract: The present invention provides abuse-resistant transdermal delivery devices containing an opioid agonist intended for analgesic purposes in pain patients.
    Type: Application
    Filed: February 15, 2005
    Publication date: September 25, 2008
    Applicant: EURO-CELTIQUE S.A.
    Inventors: Bruce Reidenberg, Ihor Shevchuk, Lino Tavares, Richard Maskiewicz, Kevin Long, Mohammed Shameem
  • TRANSDERMAL DOSAGE FORM COMPRISING AN ACTIVE AGENT AND A SALT AND A FREE-BASE FORM OF AN ADVERSE AGENT
    Publication number: 20080020028
    Abstract: This invention relates to a tamper-resistant transdermal dosage form comprising an active agent, such as an opioid, or a pharmaceutically acceptable salt thereof, a free base of an adverse agent, such as an opioid antagonist, and a pharmaceutically acceptable salt of an adverse agent, such as an opioid antagonist. The transdermal dosage form allows an effective amount of the active agent, or a pharmaceutically acceptable salt thereof, to be transdermally administered to an animal. The invention further relates to methods for treating or preventing pain in an animal comprising contacting the skin of an animal in need thereof with the transdermal dosage form of the invention for an amount of time sufficient to treat or prevent pain.
    Type: Application
    Filed: October 1, 2007
    Publication date: January 24, 2008
    Inventors: Ihor Shevchuk, Bruce Reidenberg
  • Felodipine transdermal device and methods
    Patent number: 7018649
    Abstract: A method of effectively treating hypertension in humans is achieved by administering felodipine via a transdermal formulation. Preferably, the transdermal formulation is applied to the skin of the patient and maintained in contact with the skin for at least about 24 hours days, and preferably for about 3 to about 8 days.
    Type: Grant
    Filed: October 23, 2001
    Date of Patent: March 28, 2006
    Assignee: Euro-Celtique, S.A.
    Inventors: Lino Tavares, Ihor Shevchuk, Mark Alfonso, Geraldine Marcenyac, Kirti Valia
  • Terazosin transdermal device and methods
    Publication number: 20050064022
    Abstract: A method of effectively treating benign prostatic hypertension in humans is achieved by administering amorphous terazosin via a transdermal formulation. Preferably, the transdermal formulation is applied to the skin of the patient and maintained in contact with the skin for at least about 24 hours, and preferably for about 3 to about 8 days.
    Type: Application
    Filed: October 23, 2002
    Publication date: March 24, 2005
    Inventors: Lino Tavares, Ihor Shevchuk, Mark Alfonso, Geraldine Marcenyac, Kirti Valia
  • Terazosin transdermal device & methods
    Publication number: 20050031678
    Abstract: A method of effectively treating benign prostatic hypertension in humans is achieved by administering terazosin via a transdermal formulation. Preferably, the transdermal formulation is applied to the skin of the patient and maintained in contact with the skin for at least about 24 hours, and preferably for about 3 to about 8 days.
    Type: Application
    Filed: September 20, 2004
    Publication date: February 10, 2005
    Applicant: Euro-Celtique S.A
    Inventors: Lino Tavares, Ihor Shevchuk, Mark Alfonso, Geraldine Marcenyac, Kirti Valia
  • Abuse resistant opioid containing transdermal systems
    Publication number: 20040241218
    Abstract: The present invention relates to transdermal dosage form (FIG. 1-3) comprising at least one activating agent and at least one inactivating agent. The dosage form (FIG. 1-3) releases the inactivating agent upon disruption of the dosage form (FIG. 1-3) thereby preventing or hindering misuse of the active agent contained in the dosage form (FIG. 1-3).
    Type: Application
    Filed: November 20, 2003
    Publication date: December 2, 2004
    Inventors: Lino Tavares, Bruce E Reidenberg, Richard S Sackler, Curtis Wright, Mark A Alfonso, Benjamin Oshlack, James P Cassidy, Anthony E Carpanzano, Rampurna P Gullapalli, Ihor Shevchuk
  • Transdermal dosage form comprising an active agent and a salt and free-base form of an adverse agent
    Publication number: 20040126323
    Abstract: This invention relates to a tamper-resistant transdermal dosage form comprising an active agent, such as an opioid, or a pharmaceutically acceptable salt thereof, a free base of an adverse agent, such as an opioid antagonist, and a pharmaceutically acceptable salt of an adverse agent, such as an opioid antagonist. The transdermal dosage form allows an effective amount of the active agent, or a pharmaceutically acceptable salt thereof, to be transdermally administered to an animal. The invention further relates to methods for treating or preventing pain in an animal comprising contacting the skin of an animal in need thereof with the transdermal dosage form of the invention for an amount of time sufficient to treat or prevent pain.
    Type: Application
    Filed: August 20, 2003
    Publication date: July 1, 2004
    Inventors: Ihor Shevchuk, Bruce Reidenberg
  • Acyl opioid antagonists
    Publication number: 20040033253
    Abstract: This invention relates to a tamper-resistant transdermal-delivery device comprising an opioid, or a pharmaceutically acceptable salt thereof, and an acyl opioid antagonist, or a pharmaceutically acceptable salt thereof. The transdermal-delivery device allows an analgesically effective amount of the opioid, or a pharmaceutically acceptable salt thereof, to be transdermally administered to a patient. The invention further relates to methods for treating or preventing pain in a patient comprising contacting the skin of a patient in need thereof with the transdermal-delivery device of the invention for an amount of time sufficient to treat or prevent pain. The invention further relates to acyl opioid antagonists.
    Type: Application
    Filed: February 14, 2003
    Publication date: February 19, 2004
    Inventors: Ihor Shevchuk, James P. Cassidy, Bruce Reidenberg, Dale E. Sharp, Robert J. Kupper
  • Transdermal delivery device disposal system
    Publication number: 20040033255
    Abstract: The present invention relates to a transdermal delivery device disposal system for disposing of a transdermal delivery device containing at least one pharmaceutically active component.
    Type: Application
    Filed: June 10, 2003
    Publication date: February 19, 2004
    Inventors: Carl J. Baker, Ihor Shevchuk
  • Felodipine transdermal device and methods
    Publication number: 20030072791
    Abstract: A method of effectively treating hypertension in humans is achieved by administering felodipine via a transdermal formulation. Preferably, the transdermal formulation is applied to the skin of the patient and maintained in contact with the skin for at least about 24 hours days, and preferably for about 3 to about 8 days.
    Type: Application
    Filed: October 23, 2001
    Publication date: April 17, 2003
    Inventors: Lino Tavares, Ihor Shevchuk, Mark Alfonso, Geraldine Marcenyac, Kirti H. Valia
  • Loratadine transdermal device and methods
    Publication number: 20030035828
    Abstract: A tansdermal delivery device for effectively treating seasonal allergic rhinitis and chronic idiopathic urticariain in humans is disclosed and methods thereof.
    Type: Application
    Filed: October 23, 2001
    Publication date: February 20, 2003
    Inventors: Lino Tavares, Ihor Shevchuk, Mark Alfonso, Geraldine Marcenyac, Kirti H. Valia